Fig. 2From: The assessment of mesenchymal stem cells therapy in acute on chronic liver failure and chronic liver disease: a systematic review and meta-analysis of randomized controlled clinical trialsRisk of bias assessment. A Graph of the risk of bias for the included studies, B graph of the risk of bias summary for the included studiesBack to article page